Manufacturing - Tools & Accessories
Compare Stocks
4 / 10Stock Comparison
KMT vs SWK vs AMTM vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Tools & Accessories
Aerospace & Defense
Industrial - Machinery
KMT vs SWK vs AMTM vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Manufacturing - Tools & Accessories | Manufacturing - Tools & Accessories | Aerospace & Defense | Industrial - Machinery |
| Market Cap | $2.75B | $12.60B | $5.99B | $79.14B |
| Revenue (TTM) | $2.14B | $15.23B | $14.27B | $18.32B |
| Net Income (TTM) | $137M | $371M | $180M | $2.44B |
| Gross Margin | 31.8% | 30.0% | 10.9% | 52.7% |
| Operating Margin | 9.6% | 7.8% | 4.3% | 19.8% |
| Forward P/E | 11.2x | 17.8x | 10.2x | 21.7x |
| Total Debt | $643M | $5.86B | $4.32B | $13.76B |
| Cash & Equiv. | $141M | $280M | $437M | $1.54B |
KMT vs SWK vs AMTM vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Kennametal Inc. (KMT) | 100 | 139.2 | +39.2% |
| Stanley Black & Dec… (SWK) | 100 | 73.6 | -26.4% |
| Amentum Holdings, I… (AMTM) | 100 | 76.1 | -23.9% |
| Emerson Electric Co. (EMR) | 100 | 129.2 | +29.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KMT vs SWK vs AMTM vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KMT is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.36, Low D/E 48.6%, current ratio 2.46x
- Beta 1.36, yield 2.2%, current ratio 2.46x
- +77.9% vs AMTM's +15.1%
SWK is the clearest fit if your priority is income & stability.
- Dividend streak 16 yrs, beta 1.83, yield 4.1%
- 4.1% yield, 16-year raise streak, vs EMR's 1.5%, (1 stock pays no dividend)
AMTM carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 71.6%, EPS growth 179.4%, 3Y rev CAGR 23.3%
- 71.6% revenue growth vs KMT's -3.9%
- Lower P/E (10.2x vs 21.7x)
- Beta 1.18 vs SWK's 1.83
EMR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 207.0% 10Y total return vs KMT's 96.1%
- 13.3% margin vs AMTM's 1.3%
- 5.8% ROA vs AMTM's 1.6%, ROIC 8.2% vs 4.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 71.6% revenue growth vs KMT's -3.9% | |
| Value | Lower P/E (10.2x vs 21.7x) | |
| Quality / Margins | 13.3% margin vs AMTM's 1.3% | |
| Stability / Safety | Beta 1.18 vs SWK's 1.83 | |
| Dividends | 4.1% yield, 16-year raise streak, vs EMR's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +77.9% vs AMTM's +15.1% | |
| Efficiency (ROA) | 5.8% ROA vs AMTM's 1.6%, ROIC 8.2% vs 4.3% |
KMT vs SWK vs AMTM vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
KMT vs SWK vs AMTM vs EMR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 3 of 6 categories
AMTM leads 1 • KMT leads 0 • SWK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 8.6x KMT's $2.1B. EMR is the more profitable business, keeping 13.3% of every revenue dollar as net income compared to AMTM's 1.3%. On growth, KMT holds the edge at +21.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $15.2B | $14.3B | $18.3B |
| EBITDAEarnings before interest/tax | $275M | $1.7B | $1.1B | $4.7B |
| Net IncomeAfter-tax profit | $137M | $371M | $180M | $2.4B |
| Free Cash FlowCash after capex | $73M | $726M | $797M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +31.8% | +30.0% | +10.9% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +9.6% | +7.8% | +4.3% | +19.8% |
| Net MarginNet income ÷ Revenue | +6.4% | +2.4% | +1.3% | +13.3% |
| FCF MarginFCF ÷ Revenue | +3.4% | +4.8% | +5.6% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.8% | +2.7% | -3.6% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +82.9% | -35.0% | +9.3% | +28.2% |
Valuation Metrics
AMTM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 30.1x trailing earnings, KMT trades at a 67% valuation discount to AMTM's 90.9x P/E. On an enterprise value basis, AMTM's 9.7x EV/EBITDA is more attractive than EMR's 18.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.8B | $12.6B | $6.0B | $79.1B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $18.2B | $9.9B | $91.4B |
| Trailing P/EPrice ÷ TTM EPS | 30.08x | 30.59x | 90.85x | 34.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.25x | 17.83x | 10.18x | 21.70x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 7.74x |
| EV / EBITDAEnterprise value multiple | 11.64x | 11.80x | 9.66x | 18.09x |
| Price / SalesMarket cap ÷ Revenue | 1.40x | 0.83x | 0.42x | 4.39x |
| Price / BookPrice ÷ Book value/share | 2.12x | 1.36x | 1.30x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 23.05x | 18.32x | 11.60x | 29.67x |
Profitability & Efficiency
EMR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
EMR delivers a 12.1% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $4 for AMTM. KMT carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMTM's 0.94x. On the Piotroski fundamental quality scale (0–9), AMTM scores 7/9 vs SWK's 6/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.1% | +4.1% | +4.0% | +12.1% |
| ROA (TTM)Return on assets | +5.3% | +1.7% | +1.6% | +5.8% |
| ROICReturn on invested capital | +5.9% | +5.8% | +4.3% | +8.2% |
| ROCEReturn on capital employed | +6.8% | +7.0% | +5.3% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.49x | 0.65x | 0.94x | 0.68x |
| Net DebtTotal debt minus cash | $503M | $5.6B | $3.9B | $12.2B |
| Cash & Equiv.Liquid assets | $141M | $280M | $437M | $1.5B |
| Total DebtShort + long-term debt | $643M | $5.9B | $4.3B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 5.27x | 2.07x | 1.92x | 6.46x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $15,911 today (with dividends reinvested), compared to $4,402 for SWK. Over the past 12 months, KMT leads with a +77.9% total return vs AMTM's +15.1%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.8% vs AMTM's -6.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +25.2% | +7.1% | -19.5% | +4.4% |
| 1-Year ReturnPast 12 months | +77.9% | +36.4% | +15.1% | +27.7% |
| 3-Year ReturnCumulative with dividends | +43.0% | +7.9% | -16.9% | +76.2% |
| 5-Year ReturnCumulative with dividends | -2.7% | -56.0% | -16.9% | +59.1% |
| 10-Year ReturnCumulative with dividends | +96.1% | -0.7% | -16.9% | +207.0% |
| CAGR (3Y)Annualised 3-year return | +12.7% | +2.6% | -6.0% | +20.8% |
Risk & Volatility
Evenly matched — SWK and AMTM each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMTM is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than SWK's 1.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SWK currently trades 86.8% from its 52-week high vs AMTM's 64.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.36x | 1.83x | 1.18x | 1.57x |
| 52-Week HighHighest price in past year | $43.81 | $93.37 | $38.11 | $165.15 |
| 52-Week LowLowest price in past year | $17.62 | $59.54 | $19.11 | $109.53 |
| % of 52W HighCurrent price vs 52-week peak | +82.4% | +86.8% | +64.4% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 59.0 | 35.7 | 51.4 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 2.0M | 1.6M | 2.8M |
Analyst Outlook
Evenly matched — SWK and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KMT as "Hold", SWK as "Hold", AMTM as "Hold", EMR as "Buy". Consensus price targets imply 47.9% upside for AMTM (target: $36) vs 3.9% for KMT (target: $38). For income investors, SWK offers the higher dividend yield at 4.06% vs EMR's 1.49%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $37.50 | $89.17 | $36.29 | $161.31 |
| # AnalystsCovering analysts | 23 | 37 | 11 | 41 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +4.1% | — | +1.5% |
| Dividend StreakConsecutive years of raises | 2 | 16 | — | 37 |
| Dividend / ShareAnnual DPS | $0.79 | $3.29 | — | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +0.1% | 0.0% | +1.6% |
EMR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMTM leads in 1 (Valuation Metrics). 2 tied.
KMT vs SWK vs AMTM vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KMT or SWK or AMTM or EMR a better buy right now?
For growth investors, Amentum Holdings, Inc.
(AMTM) is the stronger pick with 71. 6% revenue growth year-over-year, versus -3. 9% for Kennametal Inc. (KMT). Kennametal Inc. (KMT) offers the better valuation at 30. 1x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KMT or SWK or AMTM or EMR?
On trailing P/E, Kennametal Inc.
(KMT) is the cheapest at 30. 1x versus Amentum Holdings, Inc. at 90. 9x. On forward P/E, Amentum Holdings, Inc. is actually cheaper at 10. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — KMT or SWK or AMTM or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +59. 1%, compared to -56. 0% for Stanley Black & Decker, Inc. (SWK). Over 10 years, the gap is even starker: EMR returned +207. 0% versus AMTM's -16. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KMT or SWK or AMTM or EMR?
By beta (market sensitivity over 5 years), Amentum Holdings, Inc.
(AMTM) is the lower-risk stock at 1. 18β versus Stanley Black & Decker, Inc. 's 1. 83β — meaning SWK is approximately 55% more volatile than AMTM relative to the S&P 500. On balance sheet safety, Kennametal Inc. (KMT) carries a lower debt/equity ratio of 49% versus 94% for Amentum Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — KMT or SWK or AMTM or EMR?
By revenue growth (latest reported year), Amentum Holdings, Inc.
(AMTM) is pulling ahead at 71. 6% versus -3. 9% for Kennametal Inc. (KMT). On earnings-per-share growth, the picture is similar: Amentum Holdings, Inc. grew EPS 179. 4% year-over-year, compared to -12. 4% for Kennametal Inc.. Over a 3-year CAGR, AMTM leads at 23. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KMT or SWK or AMTM or EMR?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus 0. 5% for Amentum Holdings, Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 3. 5% for AMTM. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KMT or SWK or AMTM or EMR more undervalued right now?
On forward earnings alone, Amentum Holdings, Inc.
(AMTM) trades at 10. 2x forward P/E versus 21. 7x for Emerson Electric Co. — 11. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMTM: 47. 9% to $36. 29.
08Which pays a better dividend — KMT or SWK or AMTM or EMR?
In this comparison, SWK (4.
1% yield), KMT (2. 2% yield), EMR (1. 5% yield) pay a dividend. AMTM does not pay a meaningful dividend and should not be held primarily for income.
09Is KMT or SWK or AMTM or EMR better for a retirement portfolio?
For long-horizon retirement investors, Kennametal Inc.
(KMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 2% yield). Stanley Black & Decker, Inc. (SWK) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KMT: +96. 1%, SWK: -0. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KMT and SWK and AMTM and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KMT is a small-cap quality compounder stock; SWK is a mid-cap income-oriented stock; AMTM is a small-cap high-growth stock; EMR is a mid-cap quality compounder stock. KMT, SWK, EMR pay a dividend while AMTM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.